Combined Behavioral and Analgesic Trial for Fibromyalgia
Status:
Completed
Trial end date:
2018-07-31
Target enrollment:
Participant gender:
Summary
This is a randomized control study that involves a combination of a drug treatment,
behavioral health, and placebo controls.
Some participants will receive a medication approved by the Food and Drug Administration for
treatment of moderate to moderately severe pain called Tramadol HC1 IR. Others will receive
an inactive pill, called a placebo. There will also be 2 different types of behavioral health
treatments, Cognitive-Behavior Therapy (CBT) and Health Education (HE) both of which have
been recommended for the treatment of patients with FM by the American Pain Society.
There are 4 possible study treatment combinations:
1. Tramadol + CBT,
2. Tramadol + HE,
3. Placebo + CBT,
4. Placebo + HE.
Although Tramadol, CBT, and HE have been shown to have some benefits for FM patients, there
have been no studies that have evaluated the combination of medication and a behavioral
health treatment. The primary purpose of this study is to compare the benefits of the 4
combinations listed.